CSL plunges after CEO departure, weak earnings
CSL employees. William West | AFP | Getty Images Shares of Australian biotech firm CSL plunged 17% Wednesday after it announced that Chief Executive Officer Paul McKenzie will step down effective February, and posted weak earnings for the first half of its fiscal year ended December. Former senior executive Gordon Naylor has been appointed as…